Poor Science; Poorly Trained Scientists; Poor Policies: Major Deterrents to the War on Cancer
- Authors
-
-
Leslie C. Costello
School of Dentistry Department of Oncology and Diagnostic Sciences and the Greenebaum Cancer Center, University of Maryland, Baltimore, Maryland 21201, USA
-
- Keywords:
- Cancer, NIH policies, training of scientists, excessive molecular biology, holistic physiological/pathophysiological approach.
- Abstract
-
Although the availability of funding has been described as the major limitation on advances in cancer, the progress in the war on cancer has been deterred mainly by poor science, poorly trained scientists, and poor NIH policies. This is the result of NIH policies of its extreme focus on molecular biology (genomics, molecular genetics, molecular biology) identification of the molecular factors and pathways; which are required for the acceptability of treatment and preventive protocols. As such, this has influenced virtually all agencies that provide grants for medical research to adopt the NIH policies. This has impacted the funding of the research as well as the focus of the training of scientists. Directors of NCI Dr. Varmus (also Nobel Prize awardee) and Dr. Zerhouni had addressed this issue; and they rejected the necessity of molecular biology studies and information. NIH should return to the holistic physiological/pathophysiological approach to studies of cancer issues. This would provide the best approach for winning the war on cancer.
- Downloads
-
Download data is not yet available.
- References
-
Zerhouni E. The NIH roadmap. Science 2003; 332: 63-5. https://doi.org/10.1126/science.1091867
Leaf C. Why we're losing the war on cancer (and how to win it). Fortune 2004; 149(6): 76-82.
Costello LC. The effect of contemporary education and training of biomedical scientists on present and future medical research. Acad Med 2009; 84: 459-63. https://doi.org/10.1097/ACM.0b013e31819a7c6b
Perspective: Is NIH funding the "best science by the best scientists"? A critique of the NIH R01 research grant review policies. Acad Med 2010; 85(5): 775-9. https://doi.org/10.1097/ACM.0b013e3181d74256
National Institutes of Health. Enhancing Peer Review at NIH: Overview. Available at: http://enhancing-peer-review.nih.gov/index.html. Accessed January 18, 2010
Office of Extramural Research, National Institutes of Health. Encouraging Early Transition to Research Independence: Modifying the NIH New Investigator Policy to Identify Early Stage Investigators. Available at: http://grants.nih.gov/grants/guide/notice-files/NOT-OD-08-121.html. Accessed January 18, 2010.
Bernard C. An Introduction to the Study of Experimental Medicine. New York, NY: The Macmillan Company 1927.
- Downloads
- Published
- 15-08-2018
- Issue
- Vol. 7 No. 3 (2018)
- Section
- Articles
How to Cite
Similar Articles
- Lvcheng Jin, Yun-Xiang Zhang, Recent Advances in Pathologic Research and Targeted Therapies of Thymoma , Journal of Cancer Research Updates: Vol. 8 No. 1 (2019)
- Juan Manuel Seoane-Romero, Pablo Ignacio Varela-Centelles, Pedro Diz-Dios, Isabel Ramos-Barbosa, Javier Fernández Feijoo, Juan Seoane, Does Tumour Biological Behaviour Influence Prognosis More than Diagnostic Delay in Oral Cancer? , Journal of Cancer Research Updates: Vol. 1 No. 1 (2012)
- Mian Chen, Inorganic Nanoplatforms for Simultaneous Cancer Imaging and Therapy: Status and Challenges , Journal of Cancer Research Updates: Vol. 6 No. 1 (2017)
- Wen Deng, Bo Hu, Chun-Ling Dai, Yi-Jun Wang, Hai-Fan Chen, S. William Zito, Li-Wu Fu, Zhe-Sheng Chen, Anticancer Activity of Oldenlandia Diffusa & Viola Philippica Car , Journal of Cancer Research Updates: Vol. 2 No. 2 (2013)
- Anupam Sarma, Debabrata Barmon, J.D. Sharma, Amal Chandra Kataki, Chidananda Bhuyan, Primary Non-Hodgkin's Lymphoma of the Uterine Cervix: Report of Three Cases with Immunohistochemical Study , Journal of Cancer Research Updates: Vol. 1 No. 1 (2012)
- Wyatt Unger, Qian Tang, Danielle Summers, Wenxin Zheng, Collision Primary Tumor of the Endometrium: Large Cell Neuroendocrine Carcinoma and Endometrioid Adenocarcinoma , Journal of Cancer Research Updates: Vol. 1 No. 1 (2012)
- Michael J. Gonzalez, Jorge R. Miranda-Massari, Jorge Duconge, Miguel J. Berdiel, Jose Olalde, Ascorbic Acid in Combination with Chemotherapeutic Agents for Cancer , Journal of Cancer Research Updates: Vol. 11 (2022)
- Zahraa A.G. AL Ghuraibawi, Mohammed Mahmood Kamil, Khaleel Ibraheem Mohson, Zainab Ghazi Sadeq, Mareym M. Alkhaiat, Hematological Parameters in Liver Metastasis: A Comprehensive Clinical Evaluation for Early Detection in Iraqi Patients , Journal of Cancer Research Updates: Vol. 14 (2025)
- Parvin Mehdipour, Evolutionary Hypothesis in Cell Cycle of Breast Cancer Patients: Mosaic Phases in Single Cancer Cells , Journal of Cancer Research Updates: Vol. 11 (2022)
- Yi Zheng, Ji-Ye Yin, Ying Wang, Xiang-Ping Li, Juan Chen, Chen-Yue Qian, Xiao-Ke Wen, Wei Zhang, Hong-Hao Zhou, Zhao-Qian Liu, The Association of Genetic Polymorphisms of TNFα, TNF-R1, and TNF-R2 and Lung Cancer Chemotherapy Response , Journal of Cancer Research Updates: Vol. 3 No. 4 (2014)
You may also start an advanced similarity search for this article.